admin

Shares of Tesla Inc. (TSLA) have been decidedly rangebound over the last two months, bouncing between support around $220 and resistance at $290. The recent price action, as well as the momentum characteristics, have confirmed this…

Speaking overall, the stock market hasn’t changed course after last week’s bounce; the upside momentum is still here, albeit acting a little tentative. One piece of news that may have helped move the market higher…

If you’ve been exploring ways to take your options trading to the next level, the OptionsPlay Add-On for StockCharts is the single most impactful upgrade you can make. And now, it’s even better. Courtesy of…

President Donald Trump unveiled new plans Tuesday to swap out the retiring A-10 Warthog aircraft based out of Selfridge Air National Guard Base in Michigan with 21 brand-new F-15EX Eagle II fighter jets.  Trump shared…

A prominent NBA team owner was among three of President Donald Trump’s diplomatic nominees confirmed by the Senate on Tuesday evening. Tilman Fertitta, owner of the Houston Rockets and CEO of Landry’s Restaurants group was…

The Department of Agriculture (USDA) terminad $2.5 billion in ‘wasteful’ grants that went toward gender-based causes, the Department of Government Efficiency (DOGE) said Tuesday.  The USDA got rid of 420 grants for a savings of…

Elon Musk, the world’s richest man, is starting to transition from his role with the Department of Government Efficiency (DOGE) and is no longer working regularly from the White House, according to a report from…

The U.S. Treasury Department and the Department of Government Efficiency (DOGE) discovered that hundreds of millions of dollars in improper payment requests were identified after going live with its first automated payment system last week.…

International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years, including more than $30 billion to advance American manufacturing of its mainframe and quantum computers. “We have been…

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development.  Bourla’s remarks on the company’s first-quarter earnings call came in response…